Risk factor
Very high price volatility
Profitability factor
Favourable price performance
About
Fermenta Biotech Ltd. primarily focuses on the creation and provision of Vitamin D3. Their extensive range of offerings includes various forms like crystalline, oil, resin in oil, cold water dispersible (CWD) preparations, and feed-grade powder. These adaptable products are utilized across multiple sectors, such as in pharmaceutical injectables, soft gel capsules, premixes, and for enhancing the nutritional value of food and beverages. The company's business activities are structured into two main divisions: the Chemicals/Bulk Drug segment, which involves the production and sale of chemicals, pharmaceutical ingredients, and enzymes; and the Property segment, dedicated to leasing out real estate. Established on May 1, 1951, by Vijay Kumar Raju Datla, the firm maintains its headquarters in Mumbai, India.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair